WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that Michael Owings has been appointed to the newly created role of chief privacy officer. Owings, 55, has held the position of vice president, quality and regulatory compliance at Phase Forward since 2004, and will continue in that related role.